President Donald Trump has been noted to exhibit signs of fatigue and other health concerns, including a bandaged hand, during public appearances. Representative Sydney Kamlager-Dove, a Democrat from California, speculated via social media that Trump might be taking the Alzheimer's drug Leqembi, which is administered through infusion and can lead to side effects such as swelling and tiredness. However, there is no evidence to support that Trump is undergoing treatment for Alzheimer's or has been diagnosed with any related condition.

The White House physician has stated that Trump's recent MRI was conducted as a precaution and that the results were normal. Previous bruising on Trump's hand has been attributed to frequent handshaking and the use of aspirin, according to White House press secretary Karoline Leavitt.

Reports from the New York Times have indicated that Trump’s public schedule appears less vigorous in his second term compared to his first. Observations during a drug pricing event in the Oval Office noted that Trump seemed to doze off at times, raising concerns about his alertness during official duties. Despite these observations, Trump has publicly dismissed claims of fatigue, citing his electoral successes and economic achievements.

In recent cabinet meetings, Trump was also seen appearing to doze off, which has drawn attention and criticism regarding the optics of his leadership. Polls indicate that some of Trump's supporters are skeptical of his claims regarding his health and energy levels.